Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #22499 on Omni Health Inc (OMHE)
lesgetrich
04/22/18 1:29 PM
#22522 RE: wallstreetbuyer #22499
Les, if you to write the article now, any change you want to make about OMHE valuation?
I believe that this company, as of today, is significantly undervalued. If they are on path next summer for $16.5 million in revenue, I would target them for a pps of at least $.13/share. It could be more than double that if they complete their share restructuring. If we start seeing some real progress on their pharma grade drug, share appreciation could be huge. Consequently, I am again recommending them for a long term hold.